Biochem Pharma/Urocor Pacis
Executive Summary
Bacillus Calmett-Guerin live immunotherapy approved March 9 for the treatment of carcinoma in situ of the urinary bladder. Quebec-based Biochem will manufacture the product and Oklahoma City-based Urocor will distribute it